An intrauterine device (IUD) is an effective tool in the treatment of early-stage endometrial cancer in certain patients, according to the results of a small study presented at the International Gynecological Cancer Society’s 14th biennial meeting.
The use of NovaSure for endometrial ablation results a variety of poor pregnancy outcomes, according to a study presented by Shannon Smith, MD, at the Global Congress of the American Association of Gynecologic Laparoscopists.
Compared with older low-dose combined hormonal contraceptives (CHCs), drospirenone-containing contraceptives are associated with a higher risk of thrombotic events, according to the results of a new FDA-funded study.
According to the findings of a new intervention review and meta-analysis, neither paracervical block with lidocaine nor conscious sedation significantly reduced overall pain scores for tubal sterilization with hysteroscopy.
After unprotected sex, the copper IUD and various oral contraceptives can be used as emergency contraception. What's the most effective option?
A pilot program is dispensing birth control and emergency contraception to students at 13 NYC high schools without informing their parents. Is this a good idea?
Compared with women who do not use hormonal contraception, most women who take progestin-only contraception are not at increased risk for venous thromboembolism, according to the results of a new meta-analysis.
IUDs are a safe and effective method of contraception. Why aren't we offering them to teens?
This month, an article in a major women’s magazine reported on an “under-the-radar issue:” young women whose doctors refuse to perform tubal ligation.
In the largest study of its kind, researchers found increased risk for myocardial infarction and thrombotic stroke in women using combined estrogen-progestin contraceptives. However, news headlines tend to overstate the risk, and patients may have new concerns about the safety of their hormonal contraceptive.